Diagnostic Strategies for Early Recognition of Cancer Therapeutics–Related Cardiac Dysfunction
Cardiovascular toxicity in the form of cardiac dysfunction continues to be an obstacle for patients with cancer. Survival and quality of life of cancer survivors are frequently affected by increased incidence of cardiovascular disease. The involvement of the cardiovascular system by primary or secon...
Main Authors: | Carlos R Manrique, Michael Park, Nidhish Tiwari, Juan Carlos Plana, Mario J Garcia |
---|---|
Format: | Article |
Language: | English |
Published: |
SAGE Publishing
2017-03-01
|
Series: | Clinical Medicine Insights: Cardiology |
Online Access: | https://doi.org/10.1177/1179546817697983 |
Similar Items
-
Mitochondrial Dysfunction in Cardiac Diseases and Therapeutic Strategies
by: Yafei Huang, et al.
Published: (2023-05-01) -
Diagnostic accuracy of cardiac testing for coronary artery disease in potential liver transplant recipients: A systematic review and meta-analysis
by: Nidhish Tiwari, et al.
Published: (2021-02-01) -
Early diagnostic value of high‐sensitivity cardiac troponin T for cancer treatment‐related cardiac dysfunction: a meta‐analysis
by: Xinfang Lv, et al.
Published: (2023-08-01) -
Emotion recognition dysfunction after anesthesia and cardiac surgery
by: Delin Zhang, et al.
Published: (2022-11-01) -
Cardiac Sarcoidosis—Diagnostic and Therapeutic Challenges
by: Dennis Korthals, et al.
Published: (2024-03-01)